Human Phenotype Ontology 
Grandparent Node:
expand
Abnormal cerebellum morphology (HP:0001317)help
Grandparent Node:
expand
Abnormality of coordination (HP:0011443)help
Parent Node:
expand
Ataxia (HP:0001251)help
..Starting node
..expand
Dysdiadochokinesis (HP:0002075)help
Term ID: 2075
Name: Dysdiadochokinesis
Synonym: Difficulty performing quick and alternating movements; Dysdiadochokinesia
Definition: A type of ataxia characterized by the impairment of the ability to perform rapidly alternating movements, such as pronating and supinating his or her hand on the dorsum of the other hand as rapidly as possible.
Comments:
Reference: HP:0002075
Genes and Diseases:
 
       Child Nodes:

 Sister Nodes: 
..expandCerebellar ataxia associated with quadrupedal gait (HP:0009878) help
..expandDysmetria (HP:0001310) help
..expandDyssynergia (HP:0010867) help
..expandEpisodic ataxia (HP:0002131) help
..expandGait ataxia (HP:0002066) help
..expandLimb ataxia (HP:0002070) help
..expandNonprogressive cerebellar ataxia (HP:0002470) help
..expandProgressive cerebellar ataxia (HP:0002073) help
..expandSpastic ataxia (HP:0002497) help
..expandTruncal ataxia (HP:0002078) help
InputHPO IDHPO termDistanceGeneGene id entrezHGNC IDDiseaseIdDiseaseNameFrequencyOnsetHGMD variantsClinVar variants
 
HPO disease - gene - phenotype typical associations:
 
HPO disease - gene - phenotype less frequent non-typical associations:
HP:0002075HP:0002075Dysdiadochokinesis0ABCB7 CL E G H2248OMIM:301310Anemia, sideroblastic, and spinocerebellar ataxia.35
HP:0002075HP:0002075Dysdiadochokinesis0AFG3L2 CL E G H10939315ORPHA:313772Early-onset spastic ataxia-myoclonic epilepsy-neuropathy syndromeHP:0040282 - Frequent86
HP:0002075HP:0002075Dysdiadochokinesis0AFG3L2 CL E G H10939315OMIM:614487Spastic ataxia 5, autosomal recessive.86
HP:0002075HP:0002075Dysdiadochokinesis0ATM CL E G H472795OMIM:208900ATAXIA-TELANGIECTASIA3267
HP:0002075HP:0002075Dysdiadochokinesis0ATN1 CL E G H18223033ORPHA:101Dentatorubral pallidoluysian atrophyHP:0040282 - Frequent16
HP:0002075HP:0002075Dysdiadochokinesis0ATXN1 CL E G H631010548OMIM:164400Spinocerebellar ataxia 1.19
HP:0002075HP:0002075Dysdiadochokinesis0ATXN1 CL E G H631010548ORPHA:98755Spinocerebellar ataxia type 1HP:0040283 - Occasional19
HP:0002075HP:0002075Dysdiadochokinesis0ATXN10 CL E G H2581410549OMIM:603516Spinocerebellar ataxia 10.9
HP:0002075HP:0002075Dysdiadochokinesis0ATXN10 CL E G H2581410549ORPHA:98761Spinocerebellar ataxia type 10HP:0040282 - Frequent9
HP:0002075HP:0002075Dysdiadochokinesis0ATXN2 CL E G H631110555OMIM:183090Spinocerebellar ataxia 2.11
HP:0002075HP:0002075Dysdiadochokinesis0ATXN7 CL E G H631410560ORPHA:94147Spinocerebellar ataxia type 7HP:0040282 - Frequent8
HP:0002075HP:0002075Dysdiadochokinesis0CARS1 CL E G H8331493OMIM:618891MICROCEPHALY, DEVELOPMENTAL DELAY, AND BRITTLE HAIR SYNDROME; MDBH
HP:0002075HP:0002075Dysdiadochokinesis0CAV1 CL E G H8571527OMIM:606721Lipodystrophy, familial partial, type 711
HP:0002075HP:0002075Dysdiadochokinesis0CCDC88C CL E G H44019319967OMIM:616053Spinocerebellar ataxia 40.54
HP:0002075HP:0002075Dysdiadochokinesis0CCDC88C CL E G H44019319967ORPHA:423275Spinocerebellar ataxia type 40HP:0040282 - Frequent54
HP:0002075HP:0002075Dysdiadochokinesis0CLN5 CL E G H12032076OMIM:256731Ceroid lipofuscinosis, neuronal, 5HP:0040283 - Occasional141
HP:0002075HP:0002075Dysdiadochokinesis0CLN5 CL E G H12032076ORPHA:228360CLN5 diseaseHP:0040282 - Frequent141
HP:0002075HP:0002075Dysdiadochokinesis0DAB1 CL E G H16002661ORPHA:363710Spinocerebellar ataxia type 37HP:0040282 - Frequent4
HP:0002075HP:0002075Dysdiadochokinesis0ELOVL4 CL E G H678514415OMIM:133190Spinocerebellar ataxia 34.62
HP:0002075HP:0002075Dysdiadochokinesis0ELOVL4 CL E G H678514415ORPHA:1955Spinocerebellar ataxia type 34HP:0040281 - Very frequent62
HP:0002075HP:0002075Dysdiadochokinesis0FA2H CL E G H7915221197ORPHA:171629Autosomal recessive spastic paraplegia type 35HP:0040282 - Frequent76
HP:0002075HP:0002075Dysdiadochokinesis0FA2H CL E G H7915221197OMIM:612319Spastic paraplegia 35, autosomal recessive76
HP:0002075HP:0002075Dysdiadochokinesis0FMR1 CL E G H23323775OMIM:300623Fragile X tremor/ataxia syndrome30
HP:0002075HP:0002075Dysdiadochokinesis0GCH1 CL E G H26434193OMIM:128230Dystonia, DOPA-responsive, with or without hyperphenylalaninemia86
HP:0002075HP:0002075Dysdiadochokinesis0GJB1 CL E G H27054283ORPHA:1175X-linked progressive cerebellar ataxiaHP:0040282 - Frequent107
HP:0002075HP:0002075Dysdiadochokinesis0GRID2 CL E G H28954576OMIM:616204SPINOCEREBELLAR ATAXIA, AUTOSOMAL RECESSIVE 18; SCAR1818
HP:0002075HP:0002075Dysdiadochokinesis0GRM1 CL E G H29114593ORPHA:324262Autosomal recessive congenital cerebellar ataxia due to MGLUR1 deficiencyHP:0040282 - Frequent8
HP:0002075HP:0002075Dysdiadochokinesis0GRM1 CL E G H29114593OMIM:617691SPINOCEREBELLAR ATAXIA 44; SCA448
HP:0002075HP:0002075Dysdiadochokinesis0GRM1 CL E G H29114593OMIM:614831SPINOCEREBELLAR ATAXIA, AUTOSOMAL RECESSIVE 13; SCAR138
HP:0002075HP:0002075Dysdiadochokinesis0ITPR1 CL E G H37086180OMIM:117360Spinocerebellar ataxia 29.177
HP:0002075HP:0002075Dysdiadochokinesis0ITPR1 CL E G H37086180ORPHA:208513Spinocerebellar ataxia type 29HP:0040282 - Frequent177
HP:0002075HP:0002075Dysdiadochokinesis0KCNJ10 CL E G H37666256OMIM:612780Seizures, sensorineural deafness, ataxia, mental retardation, and electrolyte imbalance.121
HP:0002075HP:0002075Dysdiadochokinesis0LMNB1 CL E G H40016637ORPHA:99027Adult-onset autosomal dominant leukodystrophyHP:0040283 - Occasional44
HP:0002075HP:0002075Dysdiadochokinesis0MRE11 CL E G H43617230ORPHA:251347Ataxia-telangiectasia-like disorderHP:0040283 - Occasional532
HP:0002075HP:0002075Dysdiadochokinesis0MRE11 CL E G H43617230OMIM:604391Ataxia-Telangiectasia-Like disorder 1.532
HP:0002075HP:0002075Dysdiadochokinesis0MSTO1 CL E G H5515429678ORPHA:502423Mitochondrial myopathy-cerebellar ataxia-pigmentary retinopathy syndromeHP:0040282 - Frequent
HP:0002075HP:0002075Dysdiadochokinesis0MSTO1 CL E G H5515429678OMIM:617675Myopathy, mitochondrial, and ataxia.
HP:0002075HP:0002075Dysdiadochokinesis0NFASC CL E G H2311429866OMIM:618356Neurodevelopmental disorder with central and peripheral motor dysfunction.
HP:0002075HP:0002075Dysdiadochokinesis0PDE8B CL E G H86228794ORPHA:228169Autosomal dominant striatal neurodegenerationHP:0040281 - Very frequent75
HP:0002075HP:0002075Dysdiadochokinesis0PDE8B CL E G H86228794OMIM:609161Striatal degeneration, autosomal dominant.75
HP:0002075HP:0002075Dysdiadochokinesis0PDGFB CL E G H51558800OMIM:213600Basal ganglia calcification, idiopathic, 1.9
HP:0002075HP:0002075Dysdiadochokinesis0PDGFRB CL E G H51598804OMIM:213600Basal ganglia calcification, idiopathic, 1.28
HP:0002075HP:0002075Dysdiadochokinesis0PLA2G6 CL E G H83989039OMIM:610217Neurodegeneration with brain iron accumulation 2B.133
HP:0002075HP:0002075Dysdiadochokinesis0POLR3B CL E G H5570330348OMIM:614381Leukodystrophy, hypomyelinating, 8, with or without oligodontia and/or hypogonadotropic hypogonadism.67
HP:0002075HP:0002075Dysdiadochokinesis0POU3F4 CL E G H54569217ORPHA:1435Xq21 microdeletion syndromeHP:0040283 - Occasional40
HP:0002075HP:0002075Dysdiadochokinesis0PPP2R2B CL E G H55219305OMIM:604326Spinocerebellar ataxia 12.5
HP:0002075HP:0002075Dysdiadochokinesis0PRDM13 CL E G H5933613998OMIM:619761CEREBELLAR DYSFUNCTION, IMPAIRED INTELLECTUAL DEVELOPMENT, AND HYPOGONADOTROPIC HYPOGONADISM; CDIDHH2
HP:0002075HP:0002075Dysdiadochokinesis0RFC1 CL E G H59819969ORPHA:504476Cerebellar ataxia with neuropathy and bilateral vestibular areflexia syndromeHP:0040282 - Frequent
HP:0002075HP:0002075Dysdiadochokinesis0SAMD9L CL E G H2192851349OMIM:619806SPINOCEREBELLAR ATAXIA 49; SCA494
HP:0002075HP:0002075Dysdiadochokinesis0SLC18A2 CL E G H657110935ORPHA:352649Brain dopamine-serotonin vesicular transport diseaseHP:0040281 - Very frequent2
HP:0002075HP:0002075Dysdiadochokinesis0SLC18A2 CL E G H657110935OMIM:618049Parkinsonism-Dystonia, infantile, 22
HP:0002075HP:0002075Dysdiadochokinesis0SLC20A2 CL E G H657510947OMIM:213600Basal ganglia calcification, idiopathic, 1.70
HP:0002075HP:0002075Dysdiadochokinesis0SLC30A10 CL E G H5553225355ORPHA:309854Cirrhosis-dystonia-polycythemia-hypermanganesemia syndromeHP:0040282 - Frequent42
HP:0002075HP:0002075Dysdiadochokinesis0SLC5A6 CL E G H888411041OMIM:619903
HP:0002075HP:0002075Dysdiadochokinesis0SLC9A1 CL E G H654811071OMIM:616291Lichtenstein-Knorr syndrome.2
HP:0002075HP:0002075Dysdiadochokinesis0SPG7 CL E G H668711237OMIM:607259Spastic paraplegia 7, autosomal recessive171
HP:0002075HP:0002075Dysdiadochokinesis0SPTBN2 CL E G H671211276ORPHA:352403Spectrin-associated autosomal recessive cerebellar ataxiaHP:0040282 - Frequent126
HP:0002075HP:0002075Dysdiadochokinesis0SPTBN2 CL E G H671211276OMIM:600224Spinocerebellar ataxia 5.126
HP:0002075HP:0002075Dysdiadochokinesis0SPTBN2 CL E G H671211276OMIM:615386Spinocerebellar ataxia, autosomal recessive 14.126
HP:0002075HP:0002075Dysdiadochokinesis0SQSTM1 CL E G H887811280OMIM:617145Neurodegeneration with ataxia, dystonia, and gaze palsy, childhood-onset.62
HP:0002075HP:0002075Dysdiadochokinesis0TTC19 CL E G H5490226006OMIM:615157Mitochondrial complex III deficiency, nuclear type 2.88
HP:0002075HP:0002075Dysdiadochokinesis0TTPA CL E G H727412404ORPHA:96Ataxia with vitamin E deficiencyHP:0040282 - Frequent62
HP:0002075HP:0002075Dysdiadochokinesis0TTPA CL E G H727412404OMIM:277460VITAMIN E, FAMILIAL ISOLATED DEFICIENCY OF62
HP:0002075HP:0002075Dysdiadochokinesis0TUBB4A CL E G H1038220774ORPHA:98805Primary dystonia, DYT4 typeHP:0040283 - Occasional66
HP:0002075HP:0002075Dysdiadochokinesis0VLDLR CL E G H743612698OMIM:224050Cerebellar ataxia, mental retardation, and dysequilibrium syndrome 1.111
HP:0002075HP:0002075Dysdiadochokinesis0WDR81 CL E G H12499726600OMIM:610185Cerebellar ataxia, mental retardation, and dysequilibrium syndrome2.27
HP:0002075HP:0002075Dysdiadochokinesis0XRCC1 CL E G H751512828OMIM:617633Spinocerebellar ataxia, autosomal recessive 26.4
HP:0002075HP:0002075Dysdiadochokinesis0XRCC4 CL E G H751812831OMIM:616541Short stature, microcephaly, and endocrine dysfunction.9


Genes (51) :ABCB7 AFG3L2 ATM ATN1 ATXN1 ATXN10 ATXN2 ATXN7 CARS1 CAV1 CCDC88C CLN5 DAB1 ELOVL4 FA2H FMR1 GCH1 GJB1 GRID2 GRM1 ITPR1 KCNJ10 LMNB1 MRE11 MSTO1 NFASC PDE8B PDGFB PDGFRB PLA2G6 POLR3B POU3F4 PPP2R2B PRDM13 RFC1 SAMD9L SLC18A2 SLC20A2 SLC30A10 SLC5A6 SLC9A1 SPG7 SPTBN2 SQSTM1 TTC19 TTPA TUBB4A VLDLR WDR81 XRCC1 XRCC4

Diseases (66) :OMIM:301310 ORPHA:313772 OMIM:614487 OMIM:208900 ORPHA:101 OMIM:164400 ORPHA:98755 OMIM:603516 ORPHA:98761 OMIM:183090 ORPHA:94147 OMIM:618891 OMIM:606721 OMIM:616053 ORPHA:423275 OMIM:256731 ORPHA:228360 ORPHA:363710 OMIM:133190 ORPHA:1955 ORPHA:171629 OMIM:612319 OMIM:300623 OMIM:128230 ORPHA:1175 OMIM:616204 ORPHA:324262 OMIM:617691 OMIM:614831 OMIM:117360 ORPHA:208513 OMIM:612780 ORPHA:99027 ORPHA:251347 OMIM:604391 ORPHA:502423 OMIM:617675 OMIM:618356 ORPHA:228169 OMIM:609161 OMIM:213600 OMIM:610217 OMIM:614381 ORPHA:1435 OMIM:604326 OMIM:619761 ORPHA:504476 OMIM:619806 ORPHA:352649 OMIM:618049 ORPHA:309854 OMIM:619903 OMIM:616291 OMIM:607259 ORPHA:352403 OMIM:600224 OMIM:615386 OMIM:617145 OMIM:615157 ORPHA:96 OMIM:277460 ORPHA:98805 OMIM:224050 OMIM:610185 OMIM:617633 OMIM:616541
 

Human Phenotype Ontology(HPO) is developed by the Human Phenotype Ontology Consortium. The version used here is December 15 2022 release.